Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The Precision Peptide test maps 14 metabolic pathways across 49 peptides and 150+ genetic insights specific to your weight loss biology
Whether the patient uses tobacco
According to NICE guideline NG28, GLP-1 receptor agonists should be considered when: Triple therapy (metformin and two other oral drugs) is not effective, not tolerated, or contraindicated The patient has a BMI 35 kg/m (or lower in people of Black, Asian and other minority ethnic groups) and specific obesity-related comorbidities The patient has a BMI 40% reduction in non-HDL cholesterol GLP-1 receptor agonist for glycaemic control and weight management (with secondary lipid benefits) Ezetimibe if non-HDL cholesterol reduction is insufficient Lifestyle interventions addressing diet, exercise, and weight Monitoring and follow-up are essential components of cholesterol management
Their treatment strategies include dietary adjustments, weight management programs , and medication management, all tailored to help patients maintain optimal kidney health
That defeats the entire purpose
